We confirmed this inhibitory effect of metformin by the IL-8 promoter luciferase assay; we found that metformin abrogated the promoter activity stimulated by LCA in a dose-dependent manner (Fig. 1C). Here, CXCL8 is linked to Leber congenital amaurosis.